Amgen wins first approval for new class of cholesterol drugs
The European Commission’s approval of the drug Repatha creates an important new option for patients who had not been able to reduce cholesterol with existing medications, said the company, based west of Los Angeles in Thousand Oaks. The injectable Repatha, also known as...
Posted On Jul 21 2015